Trials / Unknown
UnknownNCT03990675
Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids
Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids Generated From Matched Fine Needle Aspirations (FNA) and Fine Needle Biopsies (FNB)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer. Despite advances in the understanding of the mechanisms underlying PDAC pathogenesis, the impact on patient benefit is lagging. As a result, new model systems are being developed and used to fill this gap with the hope of translation into improved diagnostics and therapeutics. Organoids represent a powerful tool for research with the capacity to be applied to many key aspects of pancreatic tissue pathology. 3D organoids can be generated from endoscopic fine-needle aspiration or fine needle biopsy samples. In this study, we will evaluate and compare the growth rate of pancreatic cancer patient-derived organoids generated from matched fine needle Aspirations (FNA) and fine needle biopsies (FNB).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | FNA, FNB | Endoscopic ultrasound guided fine needle aspiration, Endoscopic ultrasound guided fine needle biopsy |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2021-08-01
- Completion
- 2022-08-01
- First posted
- 2019-06-19
- Last updated
- 2019-06-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03990675. Inclusion in this directory is not an endorsement.